BRAIN Biotech AG (0RFI)
LSE
Closed
Oct 7, 2026
Day's Range
2.7752 wk Range
2.05Overview - 0RFI - BRAIN Biotech AG
Key Statistics
Valuation
Enterprise Value
62.19M
EV / EBITDA
‪-12.08‬
Profitability
Profit Margin
‪-30.32%‬
Operating Margin
‪-19.96%‬
Return on Assets
‪-8.00%‬
Ownership
Shares Outstanding
18.05M
Float
9.09M
Held by Insiders
‪58.40%‬
Held by Institutions
‪8.49%‬
Price stats
Beta
‪0.61‬
50-Day Avg
‪4.93‬
200-Day Avg
‪4.93‬
Market Cap - 0RFI - BRAIN Biotech AG
Peers - 0RFI - BRAIN Biotech AG
Peer Comparison
Compared with companies in Specialty Chemicals listed on LSE.
- 0RFILSEBRAIN Biotech AG51.27MMarket Cap+23.24%52-week change—P/E (Trailing)‪-30.32%‬Profit Margin
- 0M2BLSELinde plc190.94BMarket Cap+6.36%52-week change41.89P/E (Trailing)‪48.83%‬Profit Margin
- 0Q4ULSENovonesis (Novozymes) B115.61BMarket Cap+7.45%52-week change33.90P/E (Trailing)‪19.31%‬Profit Margin
- 0NWFLSEAir Liquide S.A.91.79BMarket Cap+9.63%52-week change28.17P/E (Trailing)‪10.68%‬Profit Margin
- 0IFALSEEcolab Inc.79.25BMarket Cap-1.56%52-week change0.71P/E (Trailing)‪12.56%‬Profit Margin
- AMSLSEAdvanced Medical Solutions Group plc61.50BMarket Cap+22.48%52-week change141.25P/E (Trailing)‪1.57%‬Profit Margin
- 0HBHLSEAir Products and Chemicals Inc.61.05BMarket Cap+1.93%52-week change0.27P/E (Trailing)‪-0.37%‬Profit Margin
Profile Summary - 0RFI - BRAIN Biotech AG
About
BRAIN Biotech AG is a leading European technology company specializing in industrial biotechnology. Founded in 1993 and headquartered in Zwingenberg, Germany, it develops and commercializes bio-based products and solutions, including bioactive natural compounds, proprietary enzymes, high-performance microorganisms,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
